 Provider of ambulatory-focused technology solutions, NextGen Healthcare Inc NASDAQ: NXGN posted Q3 FY22 sales of 149.7 million, 6 YY, beating the consensus of 146.32 million. Recurring revenue accounted for 90 of total revenue, or 134.5 million, growing 5 YY. 